3.225
price down icon10.42%   -0.375
after-market  After Hours:  3.22  -0.005   -0.16%
loading

Heron Therapeutics Inc Stock (HRTX) Forecast

The Heron Therapeutics Inc (HRTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.2346, representing a +0.30% increase from the current price of $3.225. The highest analyst price target is $4.1958, and the lowest is $2.2735.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HRTX Price Target
Average 6.6851 (+107.29% Upside)
loading

Is Heron Therapeutics Inc (HRTX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 44.52 Neutral
STOCH(9,6) 40.40 Neutral
STOCHRSI(14) 5.4274 Buy
MACD(12,26) 0.1336 Sell
ADX(14) 33.09 Sell
William %R -97.92 Buy
CCI(14) -158.84 Sell
Buy: 2 Sell: 3 Neutral: 2
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
3.61
Sell
3.5435
Sell
MA20
3.5505
Sell
3.4691
Sell
MA50
3.0795
Buy
3.186
Buy
MA100
2.8672
Buy
2.8457
Buy
MA200
2.0762
Buy
2.4816
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, HRTX could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on HRTX, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 44.52 indicates that HRTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 40.4 indicates that HRTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.4274 indicates that HRTX is oversold. This suggests that HRTX price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 33.09 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -158.84 indicates that HRTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term HRTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Heron Therapeutics Inc financial reports and earnings history, Heron Therapeutics Inc (HRTX) stock could reach $12.81 by 2030, $12.78 by 2040 and $34.29 by 2050. See the projected annual prices until 2050 of the Heron Therapeutics Inc stock below:

  • Heron Therapeutics Inc (HRTX) is expected to reach an average price of $5.2724 in 2035, with a high prediction of $6.3731 and a low estimate of $5.5424. This indicates an $63.49% rise from the last recorded price of $3.225.
  • Heron Therapeutics Inc (HRTX) stock is projected to chart a bullish course in 2040, with an average price target of $12.29, representing an $281.19% surge from its current level. The forecast ranges from a conservative $12.29 to a sky-high $12.78.
  • Our analysts predict Heron Therapeutics Inc (HRTX) to jump 565.93% by 2045, soaring from $21.56 to an average price of $21.48, potentially reaching $21.34. While $21.56 is the low estimate, the potential upside is significant.
  • Heron Therapeutics Inc (HRTX) stock is expected to climb by 2050, reaching an average of $34.19, a $960.27% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.29 and $33.39, respectively, highlighting the market's uncertainty.

Heron Therapeutics Inc Stock (HRTX) Year by Year Forecast

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2024

Our forecast for HRTX stock price in 2024 now indicates an average price target of $6.7334 with a high forecast of $12.74 and a low forecast of $0.7303. The average prediction reflects an increase of +108.79% from the last recorded price of $3.225.
Month Average Low High Change from today's price
July, 2024 $2.728 $2.2735 $4.1958 -15.41%
August, 2024 $2.6025 $0.7303 $3.6803 -19.30%
September, 2024 $4.4845 $1.8586 $7.097 +39.05%
October, 2024 $4.1276 $2.7154 $5.2593 +27.99%
November, 2024 $7.2021 $3.9588 $7.9421 +123.32%
December, 2024 $11.72 $5.8533 $12.74 +263.31%

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2025

Heron Therapeutics Inc Stock (HRTX) is expected to reach an average price of $6.1451 in 2025, with a high prediction of $12.26 and a low estimate of $0.0312. This indicates an +90.54% rise from the last recorded price of $3.225.
Month Average Low High Change from today's price
January, 2025 $9.0273 $8.8973 $12.26 +179.91%
February, 2025 $7.2818 $6.8418 $11.05 +125.79%
March, 2025 $4.5763 $3.8263 $9.2901 +41.90%
April, 2025 $1.6631 $1.5915 $5.7924 -48.43%
May, 2025 $1.8514 $0.8153 $2.6453 -42.59%
June, 2025 $2.2459 $0.6336 $2.8759 -30.36%
July, 2025 $8.3965 $2.572 $8.5565 +160.36%
August, 2025 $3.301 $0.0312 $9.4826 +2.36%
September, 2025 $3.0355 $2.8655 $5.8133 -5.88%
October, 2025 $1.6861 $1.0861 $3.854 -47.72%
November, 2025 $2.9706 $1.2523 $4.5234 -7.89%
December, 2025 $4.6813 $2.6151 $5.3513 +45.16%

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2026

The predicted value for Heron Therapeutics Inc (HRTX) in 2026 is set at an average of $5.8897. Estimates vary from a peak of $11.23 to a trough of $0.5469, indicating an +82.63% surge from the present price of $3.225.
Month Average Low High Change from today's price
January, 2026 $6.5458 $4.1074 $7.9396 +102.97%
February, 2026 $7.4703 $5.5419 $7.5003 +131.64%
March, 2026 $6.5648 $6.4748 $11.23 +103.56%
April, 2026 $8.1554 $5.857 $9.2193 +152.88%
May, 2026 $4.9899 $4.7099 $9.6515 +54.73%
June, 2026 $6.1244 $3.726 $7.1344 +89.90%
July, 2026 $3.605 $2.875 $8.6528 +11.78%
August, 2026 $5.3395 $2.8534 $5.3895 +65.57%
September, 2026 $4.1901 $3.9601 $6.6618 +29.93%
October, 2026 $2.1546 $1.9496 $4.3463 -33.19%
November, 2026 $2.2091 $0.5469 $2.7708 -31.50%
December, 2026 $1.4698 $1.4198 $3.6598 -54.43%

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Heron Therapeutics Inc (HRTX) is $2.2273, with a high forecast of $4.3668 and a low forecast of $0.0878. This indicates an -30.94% decrease from the last price of $3.225.
Month Average Low High Change from today's price
January, 2027 $1.5143 $0.8243 $2.462 -53.05%
February, 2027 $1.2988 $1.0004 $3.8826 -59.73%
March, 2027 $1.0194 $0.1229 $1.4749 -68.39%
April, 2027 $0.2539 $0.0878 $1.9216 -92.13%
May, 2027 $0.2784 $0.2177 $0.9561 -91.37%
June, 2027 $2.721 $0.2345 $2.126 -15.63%
July, 2027 $2.1265 $2.4265 $2.3549 -34.06%
August, 2027 $2.502 $2.0242 $1.782 -22.42%
September, 2027 $4.0713 $3.2158 $3.7713 +26.24%
October, 2027 $4.4768 $4.1302 $4.3668 +38.82%
November, 2027 $3.7523 $4.4007 $4.2985 +16.35%
December, 2027 $1.5317 $3.5317 $4.024 -52.50%

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2028

In 2028, Heron Therapeutics Inc (HRTX) is projected to reach an average price of $2.7217, with a high projection of $3.4377 and a low estimate of $2.0056. This indicates an -15.61% fall from the last price of $3.225.
Month Average Low High Change from today's price
January, 2028 $2.5772 $2.0056 $2.2972 -20.09%
February, 2028 $2.2427 $2.405 $1.9527 -30.46%
March, 2028 $2.3821 $2.3066 $2.2771 -26.14%
April, 2028 $3.1776 $2.986 $3.0776 -1.47%
May, 2028 $3.247 $3.4153 $3.1603 +0.68%
June, 2028 $2.6825 $2.7525 $3.1908 -16.82%
July, 2028 $2.818 $2.888 $2.7052 -12.62%
August, 2028 $3.0573 $2.9018 $2.8596 -5.20%
September, 2028 $2.7528 $3.0512 $3.144 -14.64%
October, 2028 $2.3783 $2.4126 $2.3733 -26.25%
November, 2028 $3.4977 $3.5177 $3.4377 +8.46%
December, 2028 $3.2732 $3.3155 $3.2516 +1.50%

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2029

The 2029 price forecast for Heron Therapeutics Inc Stock (HRTX) is $6.247 on average, with a high prediction of $12.49 and a low estimate of $0.00292. This represents an +93.70% increase from the previous price of $3.225.
Month Average Low High Change from today's price
January, 2029 $2.5426 $2.6726 $3.1221 -21.16%
February, 2029 $2.3481 $2.4231 $2.4465 -27.19%
March, 2029 $2.6236 $2.342 $2.4936 -18.65%
April, 2029 $2.9264 $2.7645 $2.6813 -9.26%
May, 2029 $2.8331 $2.8545 $2.8624 -12.15%
June, 2029 $1.914 $2.074 $2.2623 -40.65%
July, 2029 $1.3495 $1.4495 $1.6078 -58.16%
August, 2029 $0.4088 $0.4838 $1.0533 -87.32%
September, 2029 $0.0343 $0.0915 $0.3427 -98.94%
October, 2029 $0.5663 $0.00292 $0.7963 -82.44%
November, 2029 $0.4208 $0.1885 $0.8558 -86.95%
December, 2029 $13.26 $0.143 $12.49 +311.02%

Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2030

Heron Therapeutics Inc Stock (HRTX) is expected to reach an average price of $8.7092 in 2030, with a high forecast of $14.57 and a low forecast of $2.8445. This signifies an +170.05% surge from the last price of $3.225.
Month Average Low High Change from today's price
January, 2030 $12.91 $13.66 $12.81 +300.30%
February, 2030 $11.78 $12.78 $11.93 +265.29%
March, 2030 $13.66 $12.06 $12.10 +323.51%
April, 2030 $11.20 $12.53 $11.46 +247.37%
May, 2030 $10.58 $10.29 $10.89 +228.11%
June, 2030 $8.9725 $10.44 $10.23 +178.22%
July, 2030 $3.6162 $7.0912 $7.2202 +12.13%
August, 2030 $3.3022 $2.8445 $2.279 +2.40%
September, 2030 $6.4832 $3.83 $4.4932 +101.03%
October, 2030 $6.132 $5.9687 $4.722 +90.14%
November, 2030 $13.96 $7.0097 $10.32 +332.96%
December, 2030 $14.83 $15.53 $14.57 +359.97%
$85.02
price up icon 1.81%
$25.78
price down icon 1.57%
$159.38
price down icon 1.97%
$157.30
price down icon 1.93%
$88.44
price down icon 3.95%
$378.30
price down icon 2.25%
Cap:     |  Volume (24h):